Nutrigenomics and pharmacogenomics: A scientific wonderland

Social Science Information

Volumn 45, Issue 1, 2006, Pages 35-52

  Blum, Kenneth ^a,b   Chen, Thomas J H ^c,d   Blum, Seth H ^e   Downs, Bernard W ^f   Braverman, Eric R ^g   Mengucci, Julie F ^e   Meshkin, Brian ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Salugen Inc   (United States)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^d Chang Hua Christian Hospital   (China)

^e Synaptamine Inc   (United States)

^f Allied Nutraceutical Research   (United States)

^g Path Medical Research Foundation   (United States)

Author keywords

Drug nutrient response; Gene mapping; Gene nutrition interaction; Genome based response; Nutrigenomics

Indexed keywords

EID: 32944465029     PISSN: 05390184     EISSN: None     Source Type: Journal    
DOI: 10.1177/0539018406061102     Document Type: Review

References (39)

1. Ansell, S. et al. (2003) "Primer on Medical Genomics", Part VI: "Genomics and Molecular Genetics in Clinical Practice", Mayo Clinic Proceedings 78: 307-17.
2. Blum, K. and Braverman, E.R. (2000) "Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors", Journal of Psychoactive Drugs 32: 1-100.
3. Blum, K. et al. (in press) "DNA-Based Customized Nutraceutical 'Gene' Therapy Utilizing a Genoscore: A Hypothesized Paradigm Shift of a Novel Approach to the Diagnosis, Stratification, Prognosis and Treatment of Inflammatory Processes in the Human", Medical Hypothesis.
4. Busto, U.E. (2000) "Pharmacogenetics of Alcohol: Treatment Implications", Alcoholism: Clinical Experimental Research 24: 1323-6.
5. Cadman, P.E. and O'Connor, D.T. (2003) "Pharmacogenomics of Hypertension", Current Opinion in Nephrology and Hypertension 12: 61-70.
6. Campion, K. et al. (2004) "A. Genetic Manipulation in Nutrition, Metabolism, and Obesity Research", Nutrition Reviews 62: 321-30.
7. Cascorbi, I. et al. (2001) "Frequency of Single Nucleotide Polymorphisms in the P-Glycoprotein Drug Transporter MDR1 Gene in White Subjects", Clinical and Pharmacological Therapeutics 69: 169-74.
8. Chavez, A. and Chavez, M.M. (2003) "Supplement", European Journal of Clinical Nutrition 57 (Suppl.) 1: S97-S100.
9. Daniel, H. (2002) "Genomics and Proteomics: Importance for the Future of Nutrition Research", British Journal of Nutrition 87 (Suppl.): S305.
10. David, S.P. et al. (2003) "Does the DRD2-Taq1 A Polymorphism Influence Treatment Response to Bupropion Hydrochloride for Reduction of the Nicotine Withdrawal Syndrome?", Nicotine and Tobacco Research 5: 935-42.
11. Ernest, S. et al. (2003) "Nutrigenes, Functional Genomics and Systems Biology", American Society for Nutritional Sciences 133: 4267-8.
12. Evans, W.E. and Relling, M.V. (1999) "Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics", Science 286: 487-91.
13. Evans, W. et al. (2003) "Drug Therapy: Pharmacogenomics - Drug Disposition, Drug Targets, and Side Effects", The New England Journal of Medicine 348: 538-49.
14. Fogg-Johnson, N. and Merolli, A. (2000) "Nutrigenomics: The Next Wave in Nutrition Research", Nutraceuticals World 3: 86-95.
15. Gohil, K. (2002) "Genomic Responses to Herbal Extracts: Lessons from In Vitro and In Vivo Studies with an Extract of Ginko Biloba", Biochemical Pharmacology 64(5-6): 913-17.
16. Guttmacher, A.E. and Collins, F.S. (2002) "Genomic Medicine: A Primer", The New England Journal of Medicine 347: 1512-20.
17. Harada, K. et al. (2003) "Resistance to High Fat Diet - Induced Obesity and Altered Expression of Adipose-Specific Genes in HS-Deficient Mice", American Journal of Physiology and Endocrinological Metabolism 285: E1182-95.
18. Junien, C. (2001) "Colon Cancer and Nutritional Genetics: Modifier Genes", Annales de Médecine Interne 152: 337-51.
19. Kalow, W. (2001) "Pharmacogenetics, Pharmacogenomics, and Pharmacobiology", Clinical Pharmacology and Therapy 70: 1-4.
20. Kondo, T. et al. (2003) "Combination of Dopamine D2 Receptor Gene Polymorphisms as a Possible Predictor of Treatment-Resistance to Dopamine Antagonists in Schizophrenic Patients", Programme of Neuro-Psychology Biological Psychiatry 27: 921-6.
21. Loktionov, A. (2004) "Common Gene Polymorphisms and Nutrition: Emerging Links with Pathogenesis in Multifactorial Chronic Diseases", Journal of Nutritional Biochemistry 14: 426-51.
22. Lucock, M. (2000) "Folic Acid: Nutritional Biochemistry, Molecular Biology, and Role in Disease Processes", Molecular Genetics and Metabolism 71: 121-38.
23. Ma, M. et al. (2002) "Genetic Basis of Drug Metabolism", American Journal of Health-System and Pharmacy 59: 2061-9.
24. Mackeen, D. (2005) "It's in Your Genes", Smart Money: 90-5.
25. Mammes, O. et al (2001) "LEPR Gene Polymorphisms: Association with Overweight, Fat Mass and Response to Diet in Women", European Journal of Clinical Investigation 31: 398-404.
26. Noble, E.P. (2003) "D2 Dopamine Receptor Gene in Psychiatric and Neurological Disorders and its Phenotypes", American Journal of Medicine and Genetics 116B: 103-25.
27. Ordovas, J.M. (1999) "The Genetics of Serum Lipid Responsiveness to Dietary Interventions", Proceedings of the Nutrition Society 58: 171-87.
28. Ordovas, J.M. and Mooser, V. (2000) "The APOE Locus and the Pharmacogenetics of Lipid Response", Current Opinion in Lipidology 13: 113-17.
29. Otani, K. and Aoshima, T. (2000) "Pharmacogenetics of Classical and New Antipsychotic Drugs", Therapeutic Drug Monitoring 22: 118-21.
30. Paoloni-Giacobino, A. et al. (2003a) "Genomic Interaction with Disease and Nutrition", Clinical Nutrition 22: 507-14.
31. Paoloni-Giacobino, A. et al. (2003b) "Genetics and Nutrition", Clinical Nutrition 22: 429-35.
32. Sellers, T.A. (1997) "Genetic Factors in the Pathogenesis of Breast Cancer: Their Role and Relative Importance", Journal of Nutrition 127: 929S-33S.
33. Singh, R.B. and Niaz, M.A. (1999) "Genetic Variation and Nutrition in Relation to Coronary Artery Disease", Journal of the Association of Physicians of India 47: 1185-90.
34. Sul, H.S. and Wang, D. (1998) " Nutritional and Hormonal Regulation of Enzymes in Fat Synthesis: Studies of Fatty Acid Synthase and Mitochondrial Glycerol-3-Phosphate Acyltransferase Gene Transcription", Annual Review of Nutrition 18: 331-51.
35. Uhl, G.R. and Crow, R.W. (2004) "The Burden of Complex Genetics in Brain Disorders", Archives of General Psychiatry 61: 223-30.
36. Uyeda, K. et al. (2002) "Carbohydrate Responsive Element-Binding Protein (ChREBP): A Key Regulator of Glucose Metabolism and Fat Storage", Biochemical Pharmacology 63: 2075-80.
37. Wang, R. et al. (2000) "Genomic Analysis of a Nutrient Response in Arabidopsis Reveals Diverse Expression Patterns and Novel Metabolic and Potential Regulatory Genes Induced by Nitrate", Plant Cell 12: 1491-509.
38. Weinshilboum, R. (2003) "Genomic Medicine: Inheritance and Drug Response", The New England Journal of Medicine 348: 529-37.
39. Yoshioka, M. et al. (1999) "Glutathione-S-Transferase (GST) M1, T1, P1, N-Acetyltransferase (NAT) 1 and 2 Genetic Polymorphisms and Susceptibility to Colorectal Cancer", Journal Uoeh 21: 133-47.